---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-073865"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:54:08.339969+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Mark Chin resigns from Iterum board effective Dec 31, 2023

## Summary
- Mark Chin notified Company on Dec 28, 2023 of resignation from Board effective Dec 31.
- Resignation due to desire to reduce public board commitments because of new job.
- No disagreement with Company's operations, policies, or practices cited.
- Chin served on Board for over six and a half years; Company thanked him.

## SEC filing metadata
- accession: 0000950170-23-073865
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017023073865/0000950170-23-073865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017023073865/itrm-20231229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-073865
- JSON: https://secwatch.observer/filing/0000950170-23-073865.json
- Plain text: https://secwatch.observer/filing/0000950170-23-073865.txt

## Key facts
- Executive change
  Mark Chin resigned as member of the Board of Directors at Iterum Therapeutics plc.
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On December 28, 2023, Mark Chin informed management that he would be resigning as a member of the Board of Directors of Iterum Therapeutics plc (the "Company") with effect from December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017023073865/0000950170-23-073865-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.